Health and Human Services
Task Force Description
There is no sector of our economy where the hand of government is more evident than in health care. Half of what the nation spends on health care is public money, and this expansion of government involvement comes at the expense of patient control. True consumer choice leads to increased access at lower costs, while encouraging the innovation necessary to meet the growing needs of the nation’s diverse populations — the best health care system is consumer-driven, not government-driven.
The ALEC Health and Human Services Task Force has been a national leader in promoting free-market, pro-patient health care reforms at the state level. Since 2005, 38 states have enacted ALEC HHS model policy.
Meeting Information
Health and Human Services Task Force
- Subcommittee Meeting
- Tuesday, July 14, 2026
- 2:00 PM – 3:30 PM EST
- Task Force Meeting
- Friday, July 24, 2026
- 9:15 AM – 12:15 PM EST
Task Force Meeting Agenda
- 9:15 AM – Call to Order
- Introduction of New Members
- Policy Discussion: Peptides: What State Policymakers Should Know
- Policy Discussion: Direct Pay Health Care Reform: Expanding Access, Affordability, and Patient Choice
- Policy Discussion: Trump’s Executive Order on Psychedelics: Where Do We Go From Here?
- Policy Discussion: Case Study: New Hampshire’s Move to Improve Parental Rights
- Policy Discussion: Missouri’s Efforts on Fatherhood and Shared Parenting
- Consideration of New Model Policies:
- Clinical AI Services Act
- The American Peptide Access Act
- Patient Protection Act
- Foster Youth Earned Benefits Protection for Success Act
- Adoption as a Third Option Act
- Direct Primary Care Provider Referral Protection Act
- A Home for Every Child Resolution
- Statement of Principles on Healthcare Price Transparency
- Renewal of Existing Model Policy:
- Amending Synthetic Drug Control Act
- Freedom To Share at College Act
- Suicide Prevention in Higher Education Resolution
- Patients First Medicaid Reform Act
- The Foster Youth Driver’s License Act
- 12:15 PM – Adjourn
Draft Policies
- Adoption as a Third Option Act
- Direct Health Care Provider Referral Protection Act
- Patient Protection Act
- Statement Of Principles on Healthcare Price Transparency
- The American Peptide Access Act
- Clinical AI Services Act
- A Home for Every Child Resolution
- Foster Youth Earned Benefits Protection for Success Act
- The Foster Youth Driver’s License Act
- Amending Synthetic Drug Control Act
- Freedom To Share At College Act
- Suicide Prevention in Higher Education Resolution
- Patients First Medicaid Reform Act
All Model Policies
-
Adoption as a Third Option Act Draft
Section 1. Title. This Act shall be known and may be cited as the “Adoption as a Third Option Act.” Section 2. Legislative Findings and Purpose. (a) The Legislature finds that many women facing an unplanned pregnancy are presented with only two perceived…
-
Direct Health Care Provider Referral Protection Act Draft
Be it enacted by the Legislature of the State of [STATE]: Section 1. Short title. This Act may be cited as the “Direct Health Care Provider Referral Protection Act.” Section 2. Prohibition on denial of payment and cost-sharing parity. (a) A…
-
Patient Protection Act Draft
Section 1. Purpose and scope. This Act establishes conditions on the prescribing of prescription drugs causing severe adverse effects and may be cited as the Patient Protection Act. Section 2. Definitions. For purposes of this Act, the following terms have the following meanings: “Dangerous drug”…
-
Statement Of Principles on Healthcare Price Transparency Draft
Overview Every functioning market rests on one foundational requirement: buyers must know what something costs before they purchase it. That principle, taken for granted in virtually every other sector of the American economy, has been systematically absent from healthcare. The result is a system where patients regularly overpay for lower-quality care,…
-
The American Peptide Access Act Draft
Be it enacted by the State of ______________: Section 1: Peptides; Patient Right to Try. (a) As used in this Section: “Peptide” means an alpha amino acid polymer with a specific, defined sequence fewer than 40 amino acids in size, which may be used…
-
Clinical AI Services Act Draft
Section 1. Title, Findings, and Purpose (a) Short Title. This Act shall be known and may be cited as the “Clinical AI Services Act.” (b) Findings and Purpose. This Act establishes the AI Augmented & Autonomous Service Provider (AAASP) as an independent, new class of healthcare…